P3 Health Partners vs Pennant
PIII and PNTG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PIII and PNTG compare
Pennant is the larger company, worth 80 times as much as P3 Health Partners ($1.3B against $15.9M).
Pennant grew revenue faster over the last twelve months (37.9% versus 2.8% for P3 Health Partners).
Pennant keeps more of each dollar of sales as profit, with a net margin of 2.9% compared with −6.6% at P3 Health Partners.
Pennant scores higher on the StockData Score (13 against 4 for P3 Health Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PIII | PNTG |
|---|---|---|
| Size and price | ||
| Market cap | $15.9M | $1.3B |
| Share price | $2.19 | $36.50 |
| Change, 1 year | −68.0% | 46.6% |
| Change, 5 years | −99.6% | 78.5% |
| Beta (5Y) | −0.48 | 0.64 |
| Employees | 320 | 9,700 |
| StockData Score | ||
| Total score | 4 | 13 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 1 | 4 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 0 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 40.6× |
| P/S | 0.0× (better) | 1.2× |
| EV/EBITDA | – | 18.1× |
| P/FCF | – | 36.8× |
| PEG | – | 0.72 |
| FCF yield | – | 2.7% |
| Fair value | – | $29.76 |
| Margin of safety | – | −22.7% |
| Growth | ||
| Revenue growth (TTM) | 2.8% | 37.9% (better) |
| Revenue growth, 5Y average | 24.3% (better) | 19.4% |
| Net income growth (TTM) | – | 20.5% |
| EPS growth (TTM) | – | 15.4% |
| EPS growth, 5Y average | – | 10.1% |
| Profitability | ||
| Gross margin | – | 18.5% |
| Operating margin | −9.9% | 5.6% (better) |
| Net margin | −6.6% | 2.9% (better) |
| FCF margin | – | 3.1% |
| Return on equity | −221% | – |
| Return on invested capital | −62.4% | – |
| Financial health | ||
| Net debt / EBITDA | – | −0.14 |
| Interest coverage | – | 5.8× |
| Current ratio | 0.46 | 1.20 (better) |
| Altman Z-score | −0.19 | 2.65 (better) |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 65.0% | 92.7% |
| Held by insiders | 98.0% | 5.0% |
| Insider net buying, 12 months | −$824K | −$690K (better) |
| Short interest, % of float | – | 3.5% |
Go deeper
- PIII stock overview
- PIII income statement
- PIII valuation and score
- PNTG stock overview
- PNTG income statement
- PNTG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.